Doxazosin Tablet
Product Images NDC 16571-166

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 16571-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazocin-1mg (Doxazocin 1mg)

Each tablet contains Dorazosin Mesylate, USP equivalent to 1mg Doxazosin, made in India. The dosage and use information can be found in the accompanying package insert. The tablets should be stored at temperatures between 16°C to 30°C. It is important to keep this medication out of the reach of children. Manufactured for Rising Pharma Holdings, Inc., East Brunswick, NJ 08816.*

FDA Label Image

Doxazocin-2mg (Doxazocin 2mg)

This text provides information about Doxazosin tablets, with each tablet containing Doxazosin mesylate USP equivalent to 2mg of Doxazosin. It includes directions to refer to the accompanying package insert for full prescribing information and store the tablets at a temperature range of 15°C to 30°C. The manufacturer is Rising Pharma Holdings and the medication should be kept out of the reach of children. The text also mentions the issuance date of the drug information.*

FDA Label Image

Doxazocin-4mg (Doxazocin 4mg)

FDA Label Image

Doxazocin-8mg (Doxazocin 8mg)

This description is not available.*

FDA Label Image

Doxazocin-structure.jpg (Doxazocin Structure)

FDA Label Image

Figure-1 (Figure 1)

FDA Label Image

Table-3 (Table 3)

This is a report comparing the maximum flow rates in patients under different dosages of medication. The text mentions studies conducted with various dosages and their effects on the flow rates. Symptom scores, dosages, and change in baseline are also highlighted in the summary. The study evaluates the impact of specific medications on patients' maximum flow rates based on distinct dosages administered.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.